0000899243-22-016532.txt : 20220504 0000899243-22-016532.hdr.sgml : 20220504 20220504070020 ACCESSION NUMBER: 0000899243-22-016532 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220502 FILED AS OF DATE: 20220504 DATE AS OF CHANGE: 20220504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Magovcevic-Liebisch Ivana CENTRAL INDEX KEY: 0001279281 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41200 FILM NUMBER: 22889768 MAIL ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER NAME: FORMER CONFORMED NAME: Magovcevic Ivana DATE OF NAME CHANGE: 20040503 FORMER NAME: FORMER CONFORMED NAME: MARAVIC MAGOVCEVIC IVANA DATE OF NAME CHANGE: 20040209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vigil Neuroscience, Inc. CENTRAL INDEX KEY: 0001827087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-254-4445 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-02 0 0001827087 Vigil Neuroscience, Inc. VIGL 0001279281 Magovcevic-Liebisch Ivana VIGIL NEUROSCIENCE, INC. 1 BROADWAY, 7TH FLOOR, SUITE 07-300 CAMBRIDGE MA 02142 1 1 0 0 President and CEO Common Stock 2022-05-02 4 P 0 4000 3.6097 A 202687 D Common Stock 2022-05-03 4 P 0 1000 3.9402 A 203687 D The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.27 to $3.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.89 to $4.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. /s/ Jennifer Ziolkowski, Attorney-in-Fact 2022-05-04